Effect of mirtazapine versus selective serotonin reuptake inhibitors on benzodiazepine use in patients with major depressive disorder: a pragmatic, multicenter, open-label, randomized, active-controlled, 24-week trial
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of mirtazapine versus selective serotonin reuptake inhibitors on benzodiazepine use in patients with major depressive disorder: a pragmatic, multicenter, open-label, randomized, active-controlled, 24-week trial
Authors
Keywords
Depression, Mirtazapine, Benzodiazepines, Brain-derived neurotrophic factor, Serum
Journal
Annals of General Psychiatry
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-10-19
DOI
10.1186/s12991-016-0115-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study
- (2016) Shelly L Gray et al. BMJ-British Medical Journal
- Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study
- (2016) Shelly L Gray et al. BMJ-British Medical Journal
- Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies
- (2015) Brisa S. Fernandes et al. BMC Medicine
- Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia or bipolar disorder: A randomised, placebo-controlled, blinded trial
- (2015) Lone Baandrup et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Interventions for reducing benzodiazepine use in older people: meta-analysis of randomised controlled trials
- (2014) Rebecca L. Gould et al. BRITISH JOURNAL OF PSYCHIATRY
- Abnormality in serum levels of mature brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in mood-stabilized patients with bipolar disorder: A study of two independent cohorts
- (2014) Kristoffer Södersten et al. JOURNAL OF AFFECTIVE DISORDERS
- Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients
- (2014) Reiji Yoshimura et al. Annals of General Psychiatry
- Prescription patterns following first-line new generation antidepressants for depression in Japan: A naturalistic cohort study based on a large claims database
- (2013) Toshi A. Furukawa et al. JOURNAL OF AFFECTIVE DISORDERS
- Less Is More in Antidepressant Clinical Trials
- (2013) Bret R. Rutherford et al. JOURNAL OF CLINICAL PSYCHIATRY
- Benzodiazepines: Risks and benefits. A reconsideration
- (2013) David S Baldwin et al. JOURNAL OF PSYCHOPHARMACOLOGY
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders
- (2013) Michael Bauer et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder
- (2012) Taisuke Yoshida et al. PLoS One
- Benzodiazepine use and risk of dementia: prospective population based study
- (2012) S. Billioti de Gage et al. BMJ-British Medical Journal
- Serum BDNF levels before treatment predict SSRI response in depression
- (2011) Owen M. Wolkowitz et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Antidepressant monotherapy: A claims database analysis of treatment changes and treatment duration
- (2010) Dominique Milea et al. CLINICAL THERAPEUTICS
- Brain-derived neurotrophic factor as a biomarker for mood disorders: An historical overview and future directions
- (2010) Kenji Hashimoto PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Persistence and compliance to antidepressant treatment in patients with depression: A chart review
- (2009) Norifusa Sawada et al. BMC Psychiatry
- Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults.
- (2009) Raymond W. Lam et al. JOURNAL OF AFFECTIVE DISORDERS
- Mirtazapine Versus Other Antidepressants in the Acute-Phase Treatment of Adults With Major Depression
- (2009) Norio Watanabe et al. JOURNAL OF CLINICAL PSYCHIATRY
- Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphism
- (2009) Wakako Umene-Nakano et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
- (2009) Andrea Cipriani et al. LANCET
- Survey of benzodiazepine and antidepressant use in outpatients with mood disorders in Japan
- (2009) Hiroyuki Uchida et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis
- (2008) Jannette M. Parr et al. ADDICTION
- Serum Brain-Derived Neurotrophic Factor, Depression, and Antidepressant Medications: Meta-Analyses and Implications
- (2008) Srijan Sen et al. BIOLOGICAL PSYCHIATRY
- A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression
- (2008) André Russowsky Brunoni et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started